Testis Cancer: Clinical Trials

3 trials for Testis Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Unknown 1

Follow Testis Cancer: new trials by email Literature Review of Testis Cancer trials Research Report on Testis Cancer

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
Pub2Post - Prostate Cancer (Adenocarcinoma), Bladder Cancer
Phase 2CompletedUniversity of Southern California1202025-01-162026-05-06
A Biobehavioral Intervention for Young Men With Testicular Cancer
Goal-Focused Emotion Regulation Therapy (GET), Individual Supportive Psychotherapy (ISP) - Testis Cancer
Phase 2UnknownUniversity of California, Irvine1002018-11-012020-12-19
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
Brentuximab Vedotin - Germ Cell Tumors, Testis Cancer
Phase 2TerminatedNabil Adra182016-03-092019-12-10

Narrower conditions

Testicular Neoplasms (3)  ·  Adenocarcinoma (1)  ·  Carcinoma, Embryonal (1)  ·  Kidney Neoplasms (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Nonseminomatous germ cell tumor (1)  ·  Prostatic Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Male (3)  ·  Genital Neoplasms, Male (3)  ·  Gonadal Disorders (3)  ·  Male Urogenital Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Testicular Diseases (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Neoplasms by Histologic Type (2)  ·  Carcinoma (1)  ·  Female Urogenital Diseases (1)

Interventions

Brentuximab Vedotin (1)

Sponsors

Nabil Adra (1)  ·  University of California, Irvine (1)  ·  University of Southern California (1)

Countries

United States (3)

Top investigators

Costantine Albany, MD (1)

Results publications

PMID 32290859, PMID 37078969